BDBM3202 (+-)-anti-2-[[2,6-Dihydroxy-4-[[[2-(4-hydroxyphenyl)oxy]cyclopentyl]oxy]carbonyl]phenyl]carbonyl]-3-hydroxybenzoic acid::2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy)cyclopentyl]oxy}carbonyl)phenyl]carbonyl}-3-hydroxybenzoic acid::Acyclic Balanol Analog 39b

SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Oc1ccc(O)cc1

InChI Key InChIKey=NIUBYBAPAVVDMG-UHFFFAOYSA-N

Data  15 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 15 hits for monomerid = 3202   

TargetProtein kinase C alpha type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 220nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C gamma type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 250nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 20nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C epsilon type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 240nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 10nMAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 5.00E+4nMAssay Description:The activity of PKA, activated by cAMP, is measured by its ability to transfer phosphate from [gamma-32P]ATP to histone.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C alpha type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 220nMAssay Description:Inhibition of protein kinase C alphaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2010
Entry Details Article

TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 10nMAssay Description:Inhibition of protein kinase C etaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2010
Entry Details Article

TargetProtein kinase C gamma type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 250nMAssay Description:Inhibition of protein kinase C gammaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2010
Entry Details Article

TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 20nMAssay Description:Inhibition of protein kinase C deltaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2010
Entry Details Article

TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 20nMAssay Description:Inhibition of protein kinase C beta IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2010
Entry Details Article

TargetProtein kinase C epsilon type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 240nMAssay Description:Inhibition of protein kinase C epsilonMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2010
Entry Details Article

TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandPNGBDBM3202(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-(4-hydroxyphenoxy...)
Affinity DataIC50: 20nMAssay Description:Inhibition of protein kinase C beta IIMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2010
Entry Details Article